Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,968
Closed -$224K 6042
2026
Q1
$224K Sell
2,968
-287
-9% -$21.6K ﹤0.01% 1940
2025
Q4
$242K Buy
3,255
+543
+20% +$39.7K ﹤0.01% 1795
2025
Q3
$183K Buy
2,712
+174
+7% +$11.6K ﹤0.01% 1652
2025
Q2
$165K Buy
2,538
+703
+38% +$42.1K ﹤0.01% 1485
2025
Q1
$113K Buy
1,835
+335
+22% +$22.2K ﹤0.01% 1480
2024
Q4
$108K Sell
1,500
-518
-26% -$40.5K ﹤0.01% 1278
2024
Q3
$164K Buy
2,018
+434
+27% +$34.7K 0.01% 1080
2024
Q2
$117K Buy
1,584
+548
+53% +$41.1K 0.01% 1065
2024
Q1
$78.9K Buy
1,036
+120
+13% +$8.93K ﹤0.01% 1029
2023
Q4
$65.4K Buy
916
+184
+25% +$12.8K ﹤0.01% 940
2023
Q3
$50.8K Buy
732
+51
+7% +$3.85K 0.01% 766
2023
Q2
$55.1K Buy
681
+196
+40% +$16K 0.01% 637
2023
Q1
$39.1K Buy
485
+115
+31% +$9.26K 0.01% 677
2022
Q4
$27.7K Buy
+370
New +$26.3K 0.01% 631

Other funds holding HOLX

Farther Finance Advisors's HOLX Position: Q2 2026 in Review

Farther Finance Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,968 shares — an estimated $224K sold.

Farther Finance Advisors first reported a position in HOLX in Q4 2022 and held it in 14 quarters. The position peaked at $242K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Farther Finance Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 2,968 Hologic shares in Q2 2026, an estimated $224K.
  • Farther Finance Advisors first reported a position in Hologic in Q4 2022 and held it in 14 quarters.
  • Farther Finance Advisors's Hologic position peaked at $242K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.